12
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Adenoviral-Mediated Gene Transfer of Interleukin-2 in a Human Breast Cancer Cell Line and a Fresh Primary Breast Cancer Culture

&
Pages 203-208 | Published online: 09 Jul 2009

  • Stewart AK, et al. Adenovector-mediated gene delivery of interleukin-2 in metastatic breast cancer and melanoma: Results of a phase 1 clinical trial. Gene Ther. 1999;6:350-363.
  • Cusack JC Jr, Tanabe KK. Cancer gene therapy. Surg Oncol Clin North Am. 1998;7:421-469.
  • Leiming T, et al. High-efficency transduction of freshly isolated human tumor cells using adenoviral interleukin-2 vectors. Hum Gene Ther. 1996;7:1233-1239.
  • McGrory WJ, Bautista DS, Graham FL A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology. 1988;163:614-617.
  • Addison CL, et al. Intratumoral injection of an adenovirus expressing interleukin 2 induces regression and immunity in a murine breast cancer model. Proc Natl Acad Sci USA. 1995;92:8522-8526.
  • Addison CL, et al. Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors. Gene Ther. 1998;5:1400-1409.
  • Cavello F, et al. Protective and curative potential of vaccination with interleukin-2-gene-transfected cells from a spontaneous mouse mammary adenocarcinoma. Cancer Res. 1993;53:5067-5070.
  • Tsai J, Gansbacher B, Tait L, Miller F, Heppner G. Induction of antitumor immunity by interleukin-2 gene-transduced mouse mammary tumor cells versus transduced mammary stromal fibroblasts. JNCI. 1993;85:546-553.
  • Euhus DM, Kimura L, Arnold B. Expansion of CD3+CD56+ lymphocytes correlates with induction of cytotoxicity by interleukin-2 gene transfer in human breast tumor cultures. Ann Surg Oncol. 1997;4:432-439.
  • Emtage PC, Wan Y, Bramson JL, Graham FL, Gauldie J. A double recombinant adenovirus expression the costimulatory moecule B7-1 (murine) and human IL-2 induces complete tumor regression in a murine breast adenocarcinoma model. J Immunol. 1998;160:2531-2538.
  • Emtage PC, et al. Adenoviral vectors expressing lymphotactin and interleukin 2 or lymphotactin and interleukin 12 synergize to facilitate tumor regression in murine breast cancer models. Hum Gene Ther. 1999;10:697-709.
  • Putzer BM, et al. Combination therapy with interleukin-2 and wild-type p53 expression by adenoviral vectors potentiates tumor regression in a murine model of breast cancer. Hum Gene Ther. 1998;9:707-718.
  • Toloza EM et al. Transduction of murine and human tumors using recombinant adenovirus vectors. Ann Surg Oncol. 1997:4:70-79.
  • Engelhardt JF, Ye X, Doranz B, Wilson JM. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci USA. 1994;91:6196-6200.
  • Schulick AH, et al. Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries. Potential for immunosuppression and vector engineering to overcome barriers of immunity. J Clin Invest. 1997;99:209-219.
  • Bouvet M, et al. Suppression of the immune response to an adenovirus vector and enhancement of intratumoral transgene expression by low-dose etoposide. Gen Ther. 1998;5:189-195.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.